AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01585493 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Treatment as usual. Patients will be affiliated with local out-patient clinics in secondary mental health services and they will have access to their own general practitioner. No formalized extra effort will be made to ensure treatment of physical disorders.Patients will be affiliated with local out-patient clinics in secondary
Study NCT01585493 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Care coordinator
Description: Treatment as usual plus a care coordinator (with a caseload of 25 patients) who will facilitate contact to primary care in order to ensure treatment of physical health problems,
Study NCT01024348 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paracetamol
Description: in the control group, postoperative pain will managed with 1 gr paracetamol (per os) as needed (up to 4 times a day)
Study NCT05135598 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Partners for Life health behavior change program
Description: A health behavior change intervention based on partner learning, utilizing low-tech media and a workbook.
Study NCT01302327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exenatide
Description: Exenatide
Study NCT02425787 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: This is a prospective study with a semi-structured in-depth qualitative interview. Interviews will be conducted by the study PI or designee. However, in order to ensure that the interviews are conducted sensitively, the first 10 interviews will be observed and supervised by a clinically credentialed St. Jude faculty member, and an additional 10% of the interviews will be observed after that.~In order to ensure that the interviewer does not lead the participant, or in turn, that the participant does not feel limited in regards to what they believe is an appropriate or desired response, the semi-structured interview questions are general and intended to produce broad responses in regards to participant experiences.
Study NCT02425787 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus Group
Description: Focus groups will be conducted with a two-fold purpose in mind:~1. With bereaved parents: to validate the findings of the preliminary analyses of the initial interviews \&/or to suggest avenues of further inquiry to expand and more deeply define the grief journey of bereaved parents.~2. With Hematology/Oncology Fellows: to receive input regarding the applicability and use of the findings during the training and future careers of these medical providers.
Study NCT02425787 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interview
Description: The interview will be conducted by study team members and will center around legacy item-related questions.
Study NCT01585493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHANGE
Description: Treatment as usual plus affiliation to a staffmember (caseload 10) from a CHANGE team who will provide individualized, adjusted implementation of widely recognized interventions, such as smoking cessation programmes, motivational interviewing, psychoeducation plus patient involvement in monitoring health statusA multidisciplinary CHANGE team will be established. Team members will be health professionals with experience in smoking cessation programmes or exercise programmes for mentally ill, and experts with competence in dietary issues.~CHANGE treatment involve lifestyle coaching, education about diet and physical activity,16 networking and smoking cessation programs. The team members will act as lifestyle coaches for ten patients at a time, map lifestyle and explore and elicit patients' motivation for change.
Study NCT00233506 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CpG 7909
Study NCT03500653 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Curcumin
Description: 4 gr curcumin
Study NCT03500653 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 4 gr placebo
Study NCT02148341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community of Practice Facilitation
Study NCT02148341 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care
Study NCT01002014 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nipple Sparing Mastectomy
Description: Skin sparing mastectomy with preservation of the nipple areolar complex
Study NCT01700166 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Human Cord Blood derived Stem Cell injection
Description: One time intravenous (in the vein) injection with two year follow-up
Study NCT01212029 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral measures
Description: Behavioral tasks/ questionnaires
Study NCT01212029 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fNIRS Devices &amp; Application
Description: Device 1- fNIRSoft and Device 2 - NIRScout
Study NCT03509987 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: HemaCue
Description: comparing hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.
Study NCT01924299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Administered orally
Study NCT01212029 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiological measures
Description: A set of tasks.
Study NCT01924299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Description: Administered orally
Study NCT02870465 — intervention group
Intervention type: PROCEDURE
Intervention: Closed Reduction Internal Fixation
Description: K-wires placed percutaneously through the skin to achieve fixation of a hand after reduction of the fracture in a closed manner.
Study NCT01444911 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vaginal Renewal Program
Description: The Vaginal Renewal™ Program (VRP) consists of instructions on the use of a vibrating vaginal wand along with a particular water based lubricant.
Study NCT01444911 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal Dilator
Description: Still vaginal dilator with lubricant.
Study NCT04450030 — intervention group
Intervention type: DRUG
Intervention: Methyl Prednisolonate
Description: 2000mg intravenous methyl prednisolone per day for five consecutive days
Study NCT04450030 — intervention group
Intervention type: PROCEDURE
Intervention: Immunoadsorption
Description: 6 courses of tryptophane-based immunoadsorption within up to 12 days
Study NCT02538458 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 3 % hypertonic saline up to 72H
Description: Treatment by inhalation of 3 % hypertonic saline, up to 72H. Test group.
Study NCT02538458 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3 % hypertonic saline up to 24H
Description: * Treatment by inhalation of 3 % hypertonic saline, up to 24H.~* followed by 48h of placebo : isotonic saline inhalation. Placebo control group.
Study NCT00077675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telavancin
Description: Telavancin 7.5 mg/kg/day, amended to 10 mg/kg/day, IV (intravenously) for up to 14 days
Study NCT00077675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: vancomycin or antistaphylococcal penicillin
Description: Vancomycin 1 Gram IV (intravenously) every 12 hrs or nafcillin 2 Grams, oxacillin 2 Grams, or (in South Africa) cloxacillin 0.5 - 1 Gram, IV (intravenously) every 6 hrs for up to 14 days.
Study NCT02520752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INC280
Study NCT02520752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Study NCT03048435 — intervention group
Intervention type: OTHER
Intervention: EORTC QLQ CX-24
Description: Disease specific Patient Reported Outcome measurement tool developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire covers symptoms common to women with cervical cancer and captures the impact of disease and/or treatment on domains including: urologic and gastro-intestinal symptoms, sexual functioning and body image.
Study NCT03048435 — intervention group
Intervention type: OTHER
Intervention: Physician Feedback Form
Description: This Feedback form to be completed by oncologists who have had at least one consenting patient participating in this study.
Study NCT03243565 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: OM-85
Description: OM-85 is an oral bacterial lysate of 21 different strains of 8 species and sub-species of the most common respiratory tract pathogens.
Study NCT03243565 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pregelatinized starch (Starch 1500)+Mannitol+Magnesium stearate+Anhydrous propyl gallate+Sodium glutamate
Study NCT00484796 — intervention group
Intervention type: PROCEDURE
Intervention: MED-SEP
Description: intraoperative neurophysiological monitoring
Study NCT00484796 — intervention group
Intervention type: PROCEDURE
Intervention: TRI-SEP
Description: intraoperative neurophysiologic monitoring
Study NCT00484796 — intervention group
Intervention type: PROCEDURE
Intervention: neuropsychological tests
Description: neurological short- and longterm outcome
Study NCT01041950 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar drainage
Description: Lumbar CSF drainage is started after communication between the internal and external CSF-spaces is seen on CT.
Study NCT03317743 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOV140101 (IDX-1197)
Description: The dose levels will be escalated following a 3+3 dose escalation scheme.
Study NCT04188132 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EEG -BCI based Feedback for rehabilitation
Description: Subjects will undergo EEG based BCI as feedback for rehabilitation
Study NCT03672149 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cefazolin
Description: Mixing cefazolin into the CRRT solution(s) for delivery as a continuous infusion
Study NCT02527473 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dispatcher-Assisted Basic Life Support CPR Education
Description: The training program focuses on working in a team with a dispatcher, re-enacting all steps during an emergency call from recognition of cardiac arrest to performing CPR.~The one hour training session is split into four parts:~1. Video self-instruction manikin practice (30 min), including a brief introduction to AED.~2. Practice in pairs (15 min): Role-playing a simulated emergency scenario as the dispatcher and the rescuer~3. Debriefing (15 min): Questions, answers and reflection~4. Homework: Information leaflet handed out including at-home tasks such as operating the speakerphone function on the layperson's own phone
Study NCT05141838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin D
Description: Adding vitamin D preparations to the therapy in the individual required dosage to correct the deficient state
Study NCT05141838 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement
Description: Adding оral nutritional supplement to the therapy depending on the degree of protein-energy malnutrition
Study NCT02306811 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vatelizumab
Description: Pharmaceutical form:solution for infusion~Route of administration: intravenous
Study NCT01924299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: Administered orally
Study NCT05797688 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Celution System
Description: The Celution System will isolate regenerative cells, including stem cells, from fat harvested from the treatment patients.
Study NCT00944788 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: qi-gong
Description: Physical activity similar to tai-chi
Study NCT01234896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Medicated Gum
Description: Dosage Form: Gum; Dosage: 6 mg; Frequency: Once; Duration: 30 minutes
Study NCT01234896 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 4 mg Nicotine Gum
Description: Dosage Form: Gum; Dosage: 4 mg; Frequency: Once; Duration: 30 minutes
Study NCT01234896 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 2 mg Nicotine Gum
Description: Dosage Form: Gum; Dosage: 2 mg; Frequency: Once; Duration: 30 minutes
Study NCT01234896 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 4 mg Nicotine Lozenge
Description: Dosage Form: Lozenge; Dosage: 4 mg; Frequency: Once; Duration: until dissolved
Study NCT00830115 — intervention group
Intervention type: DRUG
Intervention: Pantoprazole
Description: Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily).
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug: Selumetinib
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Study NCT02685657 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Study NCT03615118 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IVR/SMS
Description: Daily SMS messages asking participants to report their mood on a 1 to 9 scale; An automated phone system for monitoring and improving self-care and health outcomes
Study NCT03615118 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SMS
Description: Daily SMS messages asking participants to report their mood on a 1 to 9 scale
Study NCT02349737 — intervention group
Intervention type: OTHER
Intervention: Exposure to BIA interference with the ICD
Description: Exposure to BIA interference with the ICD
Study NCT03946293 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: White Bread
Description: White bread made with commercial white flour with bran/fibre removed
Study NCT03946293 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Wholegrain bread
Description: Wholegrain bread made with commercial wholegrain flour.
Study NCT03946293 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Wholegrain Enzyme
Description: Wholegrain bread made with enzyme-treated commercial wholegrain flour.
Study NCT02895412 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Donor-derived WT1-CTL and P-CTL
Description: Donor-derived WT1-CTL and P-CTL.~P-CTL will be given prophylactically a minimum of 28 days after transplantation followed by administration of monthly infusions of WT1-CTL for up to four doses.
Study NCT00815204 — intervention group
Intervention type: PROCEDURE
Intervention: MRI of the pituitary
Description: Patients will undergo a T1 weighted MRI of the pituitary to measure pituitary volume
Study NCT00815204 — intervention group
Intervention type: PROCEDURE
Intervention: DEX/CRH test
Description: Subjects will have blood drawn for baseline ACTH, cortisol, and other hormones and then undergo a DEX/CRH test. Will then measure ACTH and cortisol on test.
Study NCT02255643 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Change of PMT setting
Description: The patients current motor threshold is determined and the patient is set to a new PMT (= new treatment arm)
Study NCT02255643 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Change of PMT setting
Description: The patients current motor threshold is determined and the patient is set to a new PMT (= new treatment arm)
Study NCT02520752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine
Study NCT03335293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 100 mcg Epinephrine
Description: This study will evaluate the optimal dose of epinephrine as an adjunct to spinal doses of 1.6 mL hyperbaric bupivacaine + 20 mcg preservative free fentanyl + 150 mcg preservative-free morphine.
Study NCT03335293 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: placebo comparator
Study NCT03335293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 200 mcg Epinephrine
Description: This study will evaluate the optimal dose of epinephrine as an adjunct to spinal doses of 1.6 mL hyperbaric bupivacaine + 20 mcg preservative free fentanyl + 150 mcg preservative-free morphine.
Study NCT03457480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computer-Assisted Intervention
Description: Read computer messages
Study NCT03457480 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Focus Group
Description: Attend focus group
Study NCT04588311 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epoetin Alfa 40000 UNT/ML
Description: Epoetin alfa 40,000IU 1mL pre-filled syringe given as subcutaneous injection.
Study NCT04588311 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium Chloride 0.9%
Description: Sodium Chloride 0.9% 1mL in volume given as subcutaneous injection.
Study NCT00971958 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Circumcision
Description: Neonatal circumcision using one of three non-experimental, widely available devices.
Study NCT00971958 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mogen Clamp
Description: Mogen clamp is a reusable, one-size stainless steel clamp use for neonatal circumcision.
Study NCT00971958 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Plastibell
Description: The plastibell is a one-time use device for the circumcision of male neonates, infants and children.
Study NCT00971958 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AccuCirc
Description: AccuCirc is a device used for the circumcision of male infants approved for use by the FDA up to 10 days of life.
Study NCT04335318 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy
Description: Colonoscopies performed with assistance of an AI tool that highlights the areas that are susceptible to be a polyp.
Study NCT03457480 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informational Intervention
Description: Receive text messages
Study NCT00228423 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clopidogrel 75 mg daily
Description: Daily dose of 75 mg Clopidogrel
Study NCT00228423 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: water pill daily
Description: Daily dose of water pill (placebo)
Study NCT03535779 — intervention group
Intervention type: BIOLOGICAL
Intervention: Hepatitis B
Description: The Hepatitis B virus, is a double stranded DNA virus that prevents Hepatitis B in the population
Study NCT03535779 — intervention group
Intervention type: BIOLOGICAL
Intervention: Tetanus Toxoid
Description: The Tetanus vaccine, also known as tetanus toxoid (Td/IVP), is an inactive vaccine used to prevent tetanus in the population
Study NCT03911518 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Loop drainage
Description: Loop drainage will occur via 2 small incisions, approximately 2 cm, with the cuff from the base of a sterile glove pulled through and then tied off.
Study NCT03911518 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Incision and drainage
Description: The wound will be incised with a #11 blade scalpel along the point of maximal fluctuance, approximately 2-3 cm, and then all loculations bluntly dissected with a set of Kelly clamps. After drainage of pus, the wound will be loosely packed with gauze.
Study NCT02537366 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Study NCT02537366 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02077439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hand Robotic Training
Description: Training for 20 sessions for one hour, 3-5 times per week.
Study NCT02077439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hand and Arm Robotic Training
Description: Training for 20 sessions for one hour, 3-5 times per week.
Study NCT02077439 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional therapy
Description: Training for 20 sessions for one hour, 3-5 times per week.
Study NCT03487783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aripiprazole Oral Solution
Description: Aripiprazole 2-20 mg/day (2-20 mL/day)
Study NCT03487783 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Solution
Description: Placebo 2-20 mg/day (2-20 mL/day)
Study NCT01939496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Description: One 100 mg or 300 mg over-encapsulated tablet orally (by mouth) in addition to the patient's anti-hyperglycemic agents (AHA) regimen used in accordance with local prescribing information.
Study NCT01939496 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One matching placebo capsule orally in addition to the patient's anti-hyperglycemic agents (AHA) regimen used in accordance with local prescribing information.